Prescription drug · ANDA
Repaglinide NDC 62135-946
Repaglinide .5 mg/1 · Tablet · Oral · Chartwell RX, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 62135-946-90 | 62135094690 | 90 TABLET in 1 BOTTLE (62135-946-90)Marketed from Apr 24, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Repaglinide
- Generic name (nonproprietary)
- repaglinide
- Active ingredients
- Repaglinide — .5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Chartwell RX, LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 078555
- Marketing start
- Listing expires
- Other FDA classes
- Potassium Channel Antagonists (Mechanism)
- Identifiers
- Product ID 62135-946_342983dc-ded9-2234-e063-6294a90ac97fSPL ID 342983dc-ded9-2234-e063-6294a90ac97fSPL set ID cb995e92-295e-4638-a064-978211f5afe1RxCUI 200256, 200257, 200258UNII 668Z8C33LUUPC 0362135948900, 0362135947903, 0362135946906
- Pharmacologic class
- Glinide
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N462135094690followed by a unit qualifier and the quantityPackage 62135-0946-90. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Label details couldn’t be retrieved right now. Open the label on DailyMed.